UnknownNCT00855270
Efficacy of Single Dose IV Hydrocortisone in PTSD (PTSD) Prevention
Medication studyAges 21–65Israel
Understand this study
Who could participate?
Listed age limits: 21 years to 65 years.
- Listed locations
- Ramat GanSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateApril 2009
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 120
- Sponsor
- Sheba Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Israel
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT00855270
- Official title
Show the full official title
The Efficacy of a Single Dose IV Hydrocortisone Given Within 6 Hours of Exposure to a Traumatic Event in PTSD Prevention
Recruitment & locations
Status unknownRamat Gan
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Sheba Medical Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Placebo and Hydrocortisone.
Who can participate?
Listed age limits: 21 years to 65 years.
